EGFR inhibitors prevent the growth of colorectal cancer cells and have shown benefit in the treatment of metastatic colorectal cancer patients, whether used as single agents or in combination with chemotherapy. The gene discussed is EGFR; the disease is metastatic colorectal cancer.